Price Alert

Trevi Therapeutics Inc. (TRVI)

NASDAQ: TRVI · Real-Time Price · USD

7.51

0.02 (0.27%)

At close: Aug 15, 2025, 3:59 PM

7.52

0.07%

After-hours: Aug 15, 2025, 04:10 PM EDT

Trevi Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	117.06M	19.37M	34.1M	16.05M	12.96M	13.81M	32.4M	25.96M	13.75M	11.65M	12.59M	66.57M	24.7M	29.11M	36.83M	29.32M	36.42M	41.57M
Short-Term Investments	86.83M	83.88M	73.53M	49.44M	56.53M	59.01M	50.57M	62.9M	80.4M	99.61M	107.92M	59.03M	53.16M	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1M	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	68K	241K	243K	256K	273K	311K	297K	297K	68K	225K	205K	922K	413K	398K	334K	667K	410K	410K
Receivables	n/a	n/a	532K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	3.34M	834K	335K	667K	830K	721K	955K	1.05M	2.08M	1.61M	1.31M	421K	382K	249K	n/a	n/a	n/a	245K
Total Current Assets	207.23M	105.62M	109.43M	67.34M	72.13M	76.77M	87.55M	93.95M	99.21M	114.2M	122.62M	127.32M	79.89M	29.84M	37.96M	30.71M	38.48M	42.16M
Property-Plant & Equipment	1.04M	1.14M	1.23M	1.32M	1.41M	1.48M	1.56M	1.65M	1.7M	1.78M	194K	121K	116K	149K	184K	222K	259K	295K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.11M	1.38M	1.47M	1.57M	1.68M	1.79M	1.86M	1.94M	1.76M	2M	399K	1.04M	1.53M	547K	518K	889K	669K	705K
Total Assets	208.34M	107M	110.9M	68.91M	73.81M	78.56M	89.4M	95.9M	100.98M	116.2M	123.02M	128.36M	81.41M	30.39M	38.48M	31.6M	39.15M	42.86M
Account Payables	2.97M	1.42M	3.41M	1.61M	1.51M	2.11M	1.81M	1.26M	1.35M	1.98M	2.86M	2.33M	3.94M	1.74M	2.85M	2.23M	3.49M	801K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.81M	3.31M	3.32M	n/a
Short-Term Debt	286K	n/a	n/a	n/a	n/a	322K	306K	292K	277K	7.48M	7M	7M	7M	7M	5.83M	4.25M	2.5M	690K
Other Current Liabilities	4.11M	1.07M	2.54M	n/a	3.43M	-322K	1.79M	2.11M	1.72M	n/a	n/a	n/a	n/a	125K	2.67M	2.35M	n/a	3.27M
Total Current Liabilities	9.24M	6.87M	10.51M	9.12M	6.75M	5.28M	5.82M	5.17M	4.71M	13.2M	13.4M	14.64M	15.43M	12.87M	12.72M	9.91M	9.41M	5.34M
Long-Term Debt	605K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.15M	3.8M	5.43M	7.06M	8.65M	10.24M	11.91M	13.52M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3K	15K	35K	n/a	n/a	n/a	n/a	202K
Total Long-Term Liabilities	605K	681K	747K	816K	884K	949K	1.03M	1.11M	1.19M	1.27M	2.16M	3.82M	5.47M	7.06M	8.68M	10.3M	12M	13.84M
Total Liabilities	9.85M	7.55M	11.26M	9.94M	7.64M	6.22M	6.86M	6.29M	5.9M	14.47M	15.56M	18.46M	20.9M	19.92M	21.4M	20.22M	21.41M	19.18M
Total Debt	891K	957K	1.03M	1.11M	1.19M	1.27M	1.34M	1.41M	1.47M	9.02M	9.18M	10.86M	12.52M	14.18M	14.63M	14.5M	14.45M	14.33M
Common Stock	122K	100K	94K	75K	73K	69K	68K	64K	63K	60K	60K	58K	40K	31K	29K	22K	21K	20K
Retained Earnings	-309.69M	-297.38M	-287.05M	-275.63M	-262.39M	-250.04M	-239.13M	-231.31M	-223.62M	-216.47M	-210.07M	-204.56M	-196.3M	-188.25M	-180.92M	-172.4M	-165.14M	-155.35M
Comprehensive Income	24K	73K	61K	139K	-84K	-67K	-29K	-217K	-248K	-88K	-122K	-263K	-135K	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	198.49M	99.46M	99.64M	58.97M	66.17M	72.33M	82.55M	89.61M	95.07M	101.73M	107.46M	109.9M	60.52M	10.46M	17.07M	11.38M	17.74M	23.68M
Total Investments	86.83M	83.88M	73.53M	49.44M	56.53M	59.01M	50.57M	62.9M	80.4M	99.61M	107.92M	59.03M	54.16M	n/a	n/a	n/a	n/a	n/a